CD79A and cancer: The GSEA results showed negative enrichment of KEGG pathways and GO terms for immune‐related pathways, including immunoglobulin complexes, antigen binding, adaptive immune responses, B‐cell receptor signaling pathways, and intestinal immune networks promoting IgA production, findings that prompted us to consider the role of PES1 in cancer immunology.